He, Yang
Brouwers, Bas http://orcid.org/0000-0001-6541-4835
Liu, Hesong
Liu, Hailan
Lawler, Katherine
Mendes de Oliveira, Edson http://orcid.org/0000-0002-7330-7826
Lee, Dong-Kee
Yang, Yongjie
Cox, Aaron R. http://orcid.org/0000-0002-3330-5746
Keogh, Julia M.
Henning, Elana
Bounds, Rebecca
Perdikari, Aliki
Ayinampudi, Vikram
Wang, Chunmei
Yu, Meng
Tu, Longlong
Zhang, Nan
Yin, Na
Han, Junying
Scarcelli, Nikolas A.
Yan, Zili
Conde, Kristine M. http://orcid.org/0000-0002-9525-4606
Potts, Camille
Bean, Jonathan C. http://orcid.org/0000-0002-8007-2383
Wang, Mengjie
Hartig, Sean M. http://orcid.org/0000-0002-2695-2072
Liao, Lan
Xu, Jianming http://orcid.org/0000-0002-8208-9162
Barroso, InĂªs http://orcid.org/0000-0001-5800-4520
Mokrosinski, Jacek
Xu, Yong http://orcid.org/0000-0002-4908-1572
Sadaf Farooqi, I. http://orcid.org/0000-0001-7609-3504
Funding for this research was provided by:
Wellcome Trust (207462/Z/17/Z)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01DK120858)
Article History
Received: 26 October 2021
Accepted: 25 October 2022
First Online: 19 December 2022
Competing interests
: I.S.F. has consulted for a number of companies involved in the development of weight loss drugs (Rhythm Pharmaceuticals, Eli Lilly and Novo Nordisk). All other authors have no competing interests.